Boule Diagnostics AB (publ) (STO: BOUL)

Boule Diagnostics AB Statistics

Total Valuation

Boule Diagnostics AB has a market cap or net worth of SEK 343.28 million. The enterprise value is 491.88 million.

Market Cap	343.28M
Enterprise Value	491.88M

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	n/a

Share Statistics

Boule Diagnostics AB has 38.83 million shares outstanding. The number of shares has increased by 16.90% in one year.

Shares Outstanding	38.83M
Shares Change (YoY)	+16.90%
Shares Change (QoQ)	+1.87%
Owned by Insiders (%)	13.86%
Owned by Institutions (%)	55.47%
Float	28.56M

Valuation Ratios

The trailing PE ratio is 16.38 and the forward PE ratio is 9.89.

PE Ratio	16.38
Forward PE	9.89
PS Ratio	0.60
PB Ratio	0.69
P/FCF Ratio	4.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.62, with an EV/FCF ratio of 6.31.

EV / Earnings	23.23
EV / Sales	0.86
EV / EBITDA	8.62
EV / EBIT	11.97
EV / FCF	6.31

Financial Position

The company has a current ratio of 1.23, with a Debt / Equity ratio of 36.94.

Current Ratio	1.23
Quick Ratio	0.86
Debt / Equity	36.94
Debt / EBITDA	3.21
Debt / FCF	2.35
Interest Coverage	3.42

Financial Efficiency

Return on equity (ROE) is 4.33% and return on invested capital (ROIC) is 3.82%.

Return on Equity (ROE)	4.33%
Return on Assets (ROA)	3.25%
Return on Capital (ROIC)	3.82%
Revenue Per Employee	2.86M
Profits Per Employee	105,885
Employee Count	200
Asset Turnover	0.72
Inventory Turnover	4.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.49% in the last 52 weeks. The beta is 0.54, so Boule Diagnostics AB's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-8.49%
50-Day Moving Average	9.26
200-Day Moving Average	10.02
Relative Strength Index (RSI)	53.38
Average Volume (20 Days)	11,504

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Boule Diagnostics AB had revenue of SEK 572.53 million and earned 21.18 million in profits. Earnings per share was 0.54.

Revenue	572.53M
Gross Profit	251.11M
Operating Income	41.10M
Pretax Income	26.30M
Net Income	21.18M
EBITDA	57.04M
EBIT	41.10M
Earnings Per Share (EPS)	0.54

Balance Sheet

The company has 34.70 million in cash and 183.30 million in debt, giving a net cash position of -148.60 million or -3.83 per share.

Cash & Cash Equivalents	34.70M
Total Debt	183.30M
Net Cash	-148.60M
Net Cash Per Share	-3.83
Equity (Book Value)	496.20M
Book Value Per Share	12.78
Working Capital	53.30M

Cash Flow

In the last 12 months, operating cash flow was 83.28 million and capital expenditures -5.37 million, giving a free cash flow of 77.91 million.

Operating Cash Flow	83.28M
Capital Expenditures	-5.37M
Free Cash Flow	77.91M
FCF Per Share	2.01

Margins

Gross margin is 43.86%, with operating and profit margins of 7.18% and 3.70%.

Gross Margin	43.86%
Operating Margin	7.18%
Pretax Margin	4.59%
Profit Margin	3.70%
EBITDA Margin	9.96%
EBIT Margin	7.18%
FCF Margin	13.61%

Dividends & Yields

Boule Diagnostics AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.90%
Shareholder Yield	-16.90%
Earnings Yield	6.11%
FCF Yield	22.69%

Stock Splits

The last stock split was on June 1, 2018. It was a forward split with a ratio of 4.

Last Split Date	Jun 1, 2018
Split Type	Forward
Split Ratio	4